TY - GEN A1 - Poraj-Kobielska, Marzena A1 - Atzrodt, Jens A1 - Holla, Wolfgang A1 - Sandvoss, Martin A1 - Gröbe, Glenn A1 - Scheibner, Katrin A1 - Hofrichter, Martin T1 - Preparation of labeled human drug metabolites and drug-drug interaction-probes with fungal peroxygenases T2 - Journal of Labelled Compounds and Radiopharmaceuticals N2 - Enzymatic conversion of a drug can be an efficient alternative for the preparation of a complex metabolite compared with a multi-step chemical synthesis approach. Limitations exist for chemical methods for direct oxygen incorporation into organic molecules often suffering from low yields and unspecific oxidation and also for alternative whole-cell biotransformation processes, which require specific fermentation know-how. Stable oxygen-transferring biocatalysts such as unspecific peroxygenases (UPOs) could be an alternative for the synthesis of human drug metabolites and related stable isotope-labeled analogues. This work shows that UPOs can be used in combination with hydrogen/deuterium exchange for an efficient one-step process for the preparation of 4'-OH-diclofenac-d6. The scope of the reaction was investigated by screening of different peroxygenase subtypes for the transformation of selected deuterium-labeled substrates such as phenacetin-d3 or lidocaine-d3. Experiments with diclofenac-d7 revealed that the deuterium-labeling does not affect the kinetic parameters. By using the latter substrate and H2 (18) O2 as cosubstrate, it was possible to prepare a doubly isotope-labeled metabolite (4'-(18) OH-diclofenac-d6). UPOs offer certain practical advantages compared with P450 enzyme systems in terms of stability and ease of handling. Given these advantages, future work will expand the existing 'monooxygenation toolbox' of different fungal peroxygenases that mimic P450 in vitro reactions. KW - Isotopic labeled synthesis KW - deuterium KW - 4'OH-diclofenac KW - paracetamol KW - phenacetin KW - lidocaine KW - unspecific/aromatic peroxygenase KW - EC 1.11.2.1; KW - human drug metabolites Y1 - 2013 UR - http://onlinelibrary.wiley.com/doi/10.1002/jlcr.3103/abstract;jsessionid=5453A37788468921BE8A03CABF2928DD.f03t02 U6 - https://doi.org/10.1002/jlcr.3103 SN - 1099-1344 VL - 56 IS - 9-10 SP - 513 EP - 519 ER - TY - GEN A1 - Kiebist, Jan A1 - Holla, Wolfgang A1 - Heidrich, Johannes A1 - Poraj-Kobielska, Marzena A1 - Sandvoss, Martin A1 - Simonis, Reiner A1 - Gröbe, Glenn A1 - Atzrodt, Jens A1 - Hofrichter, Martin A1 - Scheibner, Katrin T1 - One-pot synthesis of human metabolites of SAR548304 by fungal peroxygenases T2 - Bioorganic & Medicinal Chemistry N2 - Unspecific peroxygenases (UPOs, EC 1.11.2.1) have proved to be stable oxygen-transferring biocatalysts for H2O2-dependent transformation of pharmaceuticals. We have applied UPOs in a drug development program and consider the enzymatic approach in parallel to a conventional chemical synthesis of the human metabolites of the bile acid reabsorption inhibitor SAR548304. Chemical preparation of N,N-di-desmethyl metabolite was realized by a seven-step synthesis starting from a late precursor of SAR548304 and included among others palladium catalysis and laborious chromatographic purification with an overall yield of 27%. The enzymatic approach revealed that the UPO of Marasmius rotula is particularly suitable for selective N-dealkylation of the drug and enabled us to prepare both human metabolites via one-pot conversion with an overall yield of 66% N,N-di-desmethyl metabolite and 49% of N-mono-desmethylated compound in two separated kinetic-controlled reactions. KW - Peroxgenase Y1 - 2015 UR - http://www.sciencedirect.com/science/article/pii/S0968089615005295 U6 - https://doi.org/10.1016/j.bmc.2015.06.035 SN - 0968-0896 VL - 23 IS - 15 SP - 4324 EP - 4332 ER -